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Introduction
Researchers conducting clinical trials in multiple clinical sites 
with targeted populations face significant management challenges to 
maintain data integrity, while obtaining and retaining an adequate 
sample. These challenges can be further compounded when multiple 
institutions are involved, such as an integrated healthcare system and 
an academic-based partner. For example, communication among 
project team members can present a challenge to management of 
multi-site collaborations. Richards described communication as “the 
force that allows groups to take on their own identity” [1]. Effective 
communication for a research team is generally thought to be a 
function of pre-planning, adaption to various leadership styles, and 
organizational commitment [2-4]. However, a multi-site clinical trial 
does not necessarily fit the traditional hierarchical organizational 
model [3,5]. Within each clinical site, between clinical sites, and 
between clinical and academic collaborators, there must be common 
management strategies in place. Multi-site and multi-institutional 
studies present the added communication challenges of travel distance 
and time. 
Whether they are a clinic or academic employee, research 
coordinators, in particular, have significant responsibility for 
organizing and overseeing a site’s participation in multi-site clinical 
trials. Few organizations have exactly the same training requirements 
for coordinators and, as the number of clinical trial sites increases, 
these variations can present challenges in trial management. Training 
variability has the potential to create discrepancies among study staff 
regarding operating procedures, data collection, and record-keeping. 
A high degree of control in protocol implementation, data collection, 
and reporting has been identified as a key component in successfully 
managing multi-institutional randomized controlled trials (RCTs) and 
can be achieved, in part, through standardized training requirements 
[3,6]. 
Abstract
Purpose: Project management for multi-institutional, multi-site clinical trials poses significant challenges. We 
describe the response to challenges encountered in a 5-year National Institutes of Health multi-institutional 7-site 
randomized controlled trial of type 2 diabetes (T2DM) self-management interventions study. 
Methods: The collaborating institutions consisted of a large 220,000-member integrated healthcare system and a 
university academic health science center partner. The clinical team comprised the principal investigator and research 
coordinators covering 6 of the 7 clinical sites, while the academic team comprised the co-principal investigator, co-
investigators, and other research and clinical coordination staff. Subjects recruited for the study had a glycosylated 
hemoglobin ≥ 7.5 within the last 6 months and received primary care at the participating clinics. Patients who met the 
inclusion criteria were consented at private orientation meetings, randomized into one of 4 study arms, and followed 
every 6 months over a 24-month period for data collection.
Results: The encountered challenges concerned: 1) communication across the multiple clinic sites; 2) multi-
institutional coordinator training; 3) multiple record-keeping methods; 4) clinical access for academic personnel; 5) 
unanticipated clinical coordinator turnover; 6) subject recruitment and retention; and 7) multiple Institutional Review 
Boards (IRBs). Solutions included conducting full team weekly or bimonthly research meetings, coordinator cross-
training, adding study-specific templates with downloadable fields, developing a protocol for working with single point of 
contact in each clinic, securing commitment from the centralized clinical system to dedicate coordinator(s) to the project 
for the duration of the study period, setting explicit monthly recruitment goals for each clinic, and establishing a lead 
IRB up-front.
Conclusion: Our challenges reflect the complexity of clinical trial collaborations across clinical and academic 
partners. Of critical importance to the success of clinical/academic collaborations is the commitment by all institutions 
for advance determination of communication strategies, IRB processes, records access and storage systems, and 
online training needs.
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Although variations exist in training programs for research staff, 
the most significant factor affecting the way clinical data are collected 
is the Health Insurance Portability and Accountability Act (HIPAA). 
Designed to protect the privacy and security of patients’ personal health 
information (PHI), failure to comply with HIPAA regulations carries 
with it a risk for penalties and fines [7]. HIPAA’s non-compliance 
associated penalties, including required compliance training, are two 
statutory mechanisms designed to limit access to electronic health 
records (EHR) [8,9]. In multi-institutional research studies, however, 
when employees of academic institutions are also responsible for 
scheduling, collecting, and recording patient data, HIPAA’s statutorily 
designed limited access to EHR-based information presents a significant 
barrier. 
In their 2010 study of methodological challenges to conducting a 
multi-site RCT of massage therapy in hospice, Kutner et al. reported an 
average turnover rate of 68% among study staff. Reasons for coordinator 
turnover included employees leaving the organization and competition 
for experienced coordinators, even within the home organization [4]. 
Turnover of key study staff can have a particularly devastating impact 
on multi-site studies, where standardized subject recruitment and 
retention plans are essential. 
Recruitment and retention of subjects is challenging for all aspects 
of any research study [10-12]. Engaging study participants throughout 
the course of the study enhances retention, despite adding another layer 
of complexity to the coordinator role [13]. Regular communication 
between clinical trial participants and study coordinators to establish 
some level of trust may be necessary to enhance compliance and 
retention, however, engaging study participants throughout the course 
of a longitudinal RCT – and across multiple sites – is a challenge even 
for the most experienced coordinator. 
A recent literature review on institutional review boards (IRBs) 
in the United States examined IRB structures, processes, outcomes, 
and variations. Inefficiencies were found to exist in multicenter 
reviews, as interpretations of federal regulations can be inconsistent 
between institutions [14]. Additional IRB-related challenges to multi-
institutional studies have ranged from non-standard submission 
formats and review criteria to delays in processing requests due to 
multiple IRB involvement [15-18]. 
We describe the strategies and responses to the challenges 
encountered in a 5-year National Institutes of Health (NIH) funded 
multi-institutional, 7-site randomized controlled trial of type 2 diabetes 
(T2DM) self-management interventions study in a primary care setting 
under the supervision of two IRBs.
Methods 
The project was an NIH-funded study to examine the impact of self-
management interventions on clinical and self-care outcomes in adults 
with type 2 diabetes (T2DM). The interventions were: 1) participation 
in the 6 session Chronic Disease Self-management Program (CDSMP) 
developed by Stanford University [19]; 2) use of a Personal Digital 
Assistant (PDA) Tungsten E2 model; 3) participation in both the 
CDSMP and use of the PDA; and 4) control, i.e., usual care. 
The two collaborating institutions included a large 220,000-member 
integrated healthcare system from which all subjects were recruited 
and an academic health science center partner. The clinical team 
comprised the principal investigator and research coordinators 
covering 6 of the 7 clinical sites, while the academic team comprised 
the co-principal investigator, co-investigators, and other research and 
clinical coordination staff. All subjects received primary care at one of 
the 7 participating clinics. One clinic, located in an urban setting, had a 
university-based employee as its research coordinator, while the other 6 
clinics used coordinators employed by the healthcare system. 
Adults with a glycosylated hemoglobin (HbA1c) ≥ 7.5 within the 
last 6 months and no reports of alcoholism or drug abuse during the 
same time period were considered as potential subjects. Seventy-four 
doctors at the 7 clinic locations assisted with subject recruitment by 
signing letters inviting participation to a list of their qualifying patients. 
Over a 2½-year enrollment period, 5098 recruitment letters were mailed 
to qualifying patients. Other recruitment strategies included posters in 
the clinic lobbies and oral referrals by physicians and patient educators. 
Research coordinators screened by telephone a total of 1897 
patients. Three hundred and seventy-six patients who met all inclusion 
criteria, after being screened by telephone, were consented at private 
orientation meetings, enrolled, and randomized into one of the 4 
arms of the study – educational intervention (CDSMP), technology 
intervention (PDA), both, or control – to determine the potential 
impact of these interventions on HbA1c in adults with T2DM. 
During the orientation visit, a baseline survey, vital signs, and clinical 
measurements were obtained. Follow-up visits to obtain updated vital 
signs and HbA1c laboratory values and to repeat the survey on health, 
physical activity, and diabetes self-care, were scheduled at 6, 12, 18, and 
24 months. Details of the study have been published elsewhere [20,21].
The project management plan that was initially proposed included 
having weekly face-to-face meetings of the co-Principal investigators 
and key personnel, bi-monthly conference calls with the full research 
team, frequent separate meetings among the coordinators, especially 
prior to the full research team conference call, and biannual face-
to-face retreats. The twice monthly conference calls with the entire 
research team provided an opportunity to identify challenges, which 
were documented by the academic research team coordinator or 
clinical administrative assistant during the course of the project. 
Solutions were discussed in regular team meetings and typically 
required follow-up by coordinators from both institutions. This article 
represents a synthesis of major challenges and solutions identified and 
acted upon by the project team leadership. 
Results
The specific management challenges encountered during our 
project are summarized in Table 1. These challenges can be categorized 
into the following areas: 1) communication across multiple clinical sites 
and institutions, and between investigators; 2) variations in coordinator 
training requirements; 3) variations in record-keeping methods; 
4) limited accessibility to facilities and EHR by key academic study 
personnel; 5) high clinical coordinator turnover; 6) subject recruitment 
and retention; and 7) use of multiple IRBs.
For example, we experienced an 86% turnover among the research 
coordinators, often due to re-assignments within the same healthcare 
system. This made consistent coverage at clinic sites especially 
challenging. Additionally, participant attrition was identified as a 
major challenge. 18% of the subjects withdrew completely prior to 
the 24-month study completion. A much larger percentage withdrew 
from active participation, but allowed continued access to their EHR 
for laboratory results (HbA1c) and vital signs. Our organizational 
responses and strategies for addressing the challenges experienced by 
our coordinators during this multi-site, multi-institutional study are 
presented in Table 2.
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Discussion
The new emphasis on team science and translational studies in real 
world settings brings opportunities for increasing the positive impacts 
of science [22,23]. However, as the number of partnering organizations 
increase the challenges of conducting multi-site clinical investigations 
are often multiplied as seen in this study.
Fostering collaborative communication styles 
As stated previously, a multicenter clinical trial does not fit into 
a traditional model of hierarchical management, as the clinical team 
does not manage the academic staff and vice versa. It does however, 
appear to fit into a traditional model of matrix management, especially 
if collaborators agree at the beginning to see the co-principal 
investigators as equal and the coordinators from each entity as also 
equal. This necessitates the importance of collaboration, rather than 
direct management, in areas that include communications, IRB roles, 
and operating procedures. 
Over our five-year research study, weekly and later bi-monthly, 
teleconferences were established for the full research team. Separate 
coordinator meetings were held in advance of the full team meetings 
for clarifications on minor recruitment issues and to agree on priority 
questions for the co-principal investigators. As recommended by 
Aitken [24], face-to-face biannual retreats were held twice a year and 
included all team members. This ensured that all team members were 
able to share information and contribute ideas to assist with continuity 
for the project.
In their study of the methodological challenges in conducting 
a multi-site RCT, Kutner et al. identified communication as one the 
Challenges Recommended Solutions and Opportunities 
Communication across multiple clinic sites •	 Conducted weekly or bimonthly research meetings for the full team via phone. •	 Conducted separate coordinator meetings for clarification on minor recruitment issues (≥ 1 representative per clinic site). 
Multi-institutional coordinator training •	 Conducted coordinator cross-training
Multiple record-keeping methods
•	 Added study-specific templates with downloadable fields to the EHR.
•	 Provided uniform data collection forms (paper forms w/Access database or data entry directly into netbook/laptop).
•	 Developed a policy for obtaining and maintaining consistent access for external personnel despite changes in compliance 
staff. 
•	 Implemented a secure method of transporting and housing of records with PHI and maintain consistent policy.
Academic personnel needing clinic access •	 Developed a protocol for working with single point of contact in each clinic (e.g., research nurse-coordinators).
High clinical coordinator turnover 
•	 Secured commitment from the centralized clinical system to dedicate coordinator(s) to the project for the duration of the 
study period.
•	 Conducted biweekly coordinator meetings.
•	 Developed an online standard operating procedures manual.
•	 Supported Quality Assurance (internal audits) to assess and correct inconsistencies between sites and coordinators and 
ensure data integrity.
Subject recruitment and retention
•	 Set explicit monthly recruitment goals for each clinic
•	 Monitored recruitment via monthly progress reporting and tracking
•	 Provided option for passive withdrawal form study
•	 Provided option for phone follow-up instead of in-person visit
Multiple Institutional Review Boards
•	 Established a lead IRB up-front.
•	 Submitted protocol and addendums to secondary IRBs only after approval is received from lead IRB, as changes may be 
mandated by one or both IRBs.
•	 Maintained a single/same version of currently-approved consent form.
•	 Required Co-PIs to receive correspondence from both the clinical and academic IRBs.
Table 2: Solution approaches used and recommended for improved management of clinical trial collaborations. 
•	 Communication across multiple clinic sites separated by up to 100 miles 
o	 infrequency of face-to-face meetings
o	 travel time between clinics and appointments 
•	 Multi-institutional coordinator training 
o	 variation in academic research management and clinical coordinator training
•	 Multiple record keeping methods 
o	 non-access to academic servers for clinical personnel
o	 non-access to EHR for academic personnel
o	 maintenance of patient files off-site
•	 Academic personnel needing clinic access
o	 non-access to clinic after hours, locked doors, or room reservation calendar for academic personnel 
•	 High clinical coordinator turnover
o	 issues around consistency of training and retraining
o	 reduced treatment fidelity
o	 potential impact on data integrity
o	 opportunity for missed follow-ups 
•	 Subject recruitment and retention
o	 various levels of withdrawal
o	 substituting phone interviews for face-to-face during follow-up
•	 Multiple Institutional Review Boards 
o	 varying submission formats
o	 varying research training requirements 
o	 variation in review criteria
o	 delays in the processing of submitted forms
Table 1: Specific challenges encountered in our multi-site, multi-institutional clinical trial collaborations. 
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three key qualities that characterized successful on-site study teams 
[4]. Naydeck et al. suggested the use of operational memos, as well as 
regular conference calls between the coordinating center and other 
components of a project [3]. Specifically, they emphasized written and 
verbal communication between on-site study coordinators and their 
teams, and with their university-based research team. In the present 
study, biweekly conference calls were employed. Sequential operational 
memos that detailed standard operating procedures were not utilized, 
but might have been found useful. 
Another communication strategy that could have been used is the 
establishment of a dedicated “hotline” (or even single point of contact), 
especially during the recruitment phase, to handle questions from the 
coordinators at the clinical sites [5,25]. Review of questions posed to the 
hotline at weekly staff meetings could have supported more consistent 
responses and protocol interpretation across sites. While we did not 
use this strategy in this study, we recommend it as a means to handle 
questions expeditiously including allocating appropriate resources for 
it. 
Promoting continuity through team members 
Almost all of our clinical coordinators (13 of the 14) were 
employed by the healthcare organization and “loaned” to the project 
for finite periods of time, with hours billed directly to the study. This 
system did not encourage a sense of ownership of the project and 
was often confusing to the subjects – as some subjects spoke to a 
different coordinator for every follow-up visit. Data collection policies 
were sometimes applied inconsistently due in part to the lack of 
written operational documentation and, possibly, due to the transient 
assignments of many of the coordinators. Travel time between the 7 
clinics and between appointments placed an additional burden on the 
coordinators assigned to the more remote clinics.
However, continuity in the clinical coordinator team was established 
in January 2010, when a new coordinator was assigned to supervise 
coordinators for 6 of the 7 clinical sites. This included supervising 
coordinator training, standardizing data collection methods and 
defining visit flow, developing and implementing coordinator training 
(and making this a requirement for any coordinators assigned to the 
study to  “help temporarily”), general supervision of coordinators 
(including regular communication about progress), and quality 
control. Her leadership allowed the research team to establish clear, 
performance-oriented recruitment goals and deadlines, and establish 
consistent policies for communication and compliance between the 
clinical coordinators. Standardizing protocol training, as recommended 
by Robb et al. [6] assures that project staff have equivalent training 
experiences and are equipped to consistently deliver study protocols, 
regardless of when they join the study team.
Enhancing data access 
In collaborative clinical trials, when employees of academic 
institutions are responsible for meeting with subjects to collect and 
record data, lack of access to the EHR can present a challenge. Our 
study progression was slowed by varying viewpoints on clinical liability 
(e.g., access to participating subjects’ EHR to record vital signs), inter-
institutional record keeping (e.g., the issue of maintaining files off-site), 
and even access to physical facilities (e.g., locked doors for appointments 
scheduled after 5 p.m.). Frequent and effective communications, 
instigated by the co-principal investigators, were largely responsible 
for reducing the potential negative impact of these issues. Ultimately, 
the coordinator employed by an academic institution was given access 
to the EHR for patients participating as subjects in this study. Also, 
establishing a single point of contact at each participating clinic ensured 
that clinic access was granted expeditiously. 
Minimizing staff turnover 
The present study used 14 different coordinators over the 5-year 
period. Twelve of the 14, or 86%, were reassigned within the host 
organization or left employment with the host organization during 
our study. The continual training and retraining of clinical staff was 
most costly in the area of “missed follow-up visits” for the designated 
time points. Coordinator turnover may also have contributed to 
irregularities in screening strategies and treatment fidelity. For example, 
some coordinators provided excellent verbal instruction on use of the 
PDA device, along with the written instructions, while others merely 
distributed the device and written instructions. The continual turnover 
of research coordinators, at most of the participating clinics, did not 
allow for the development of strong “coordinator-subject relationships.” 
It is important, therefore, to secure a commitment from the 
healthcare system for dedication of coordinator time for the duration 
of a study. Developing an online standard operating procedure manual, 
and implementing policies for online coordinator training and cross-
training, will limit disruptions due to coordinator turnover. Quality 
assurance procedures, to assess and correct inconsistencies between 
sites and coordinators, will improve treatment fidelity and maintain 
data integrity. 
Enhancing participant recruitment and retention 
Even without a high degree of coordinator turnover, participant 
recruitment and retention are generally considered the most challenging 
aspects of the research process [10-12]. Like many studies, we fell short 
of our recruitment target (we achieved 376 out of 400 subjects), and did 
not achieve our targeted 50% minority recruitment. Subject follow-ups 
were hindered by the clinical IRB halting study recruitment and follow-
up to determine the best method of record-keeping for the academic 
institution and how the academic institution could access necessary 
recruitment criteria from the EHR.
One way we found to improve the retention rate for the study was 
to offer an option for passive withdrawal, whereby a subject would not 
be contacted for follow-up surveys, but would still allow their clinical 
data from the EHR to be used. In this way, they were not required to 
maintain contact with the investigative team, but continued ongoing 
contact with their physicians. Allowing subjects to do follow-up 
surveys by phone, rather than coming into the clinic for an in-person 
visit, provided a second avenue for increasing retention. However, 
this increased coordinator load, as vital signs (blood pressure, height, 
weight) had to be manually culled from the EHR within the designated 
window for follow-up. It is worth noting that in spite of not meeting 
our recruitment target and retention, we were able to accomplish major 
study objectives. For example, we met our study timeline. Nonetheless, 
future collaborations might want to anticipate untoward consequences 
regarding time, money or both. Therefore, future studies must consider 
allocating more time and resources for subject recruitment than we did 
in this study.
Standardizing IRB policies 
Fully understanding the importance of mandated research policies 
is a critical factor in conducting successful RCTs. Institutional Review 
Boards are essential for all types of research and critical to the approval, 
periodic review, and monitoring of research [26]. Researchers are 
required to obtain IRB approval before initiating any scientific protocol 
and funding agencies mandate compliance with the respective IRBs.
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In multi-institutional studies, there may be variations in application 
formats, as well as review criteria, which can potentially lead to delays 
in processing and approvals. Gaining approval separately from the IRBs 
at each of the participating institutions can considerably tax the human 
resources, in addition to prolonging the whole process by several 
months. Indeed, we found this to be true.
In the present study, we observed institutional differences in both 
the application methods (electronic submission versus paper copy) 
and the level of scrutiny, between the two collaborating organizations 
– one a healthcare organization and one an academic institution. The 
clinic used an electronic submission format while paper copies were 
still employed at the academic health science center. The co-principal 
investigator, employed by the health science center, was given access 
to the clinical submission system, but the system was unable to set 
up a “cc” whereby the co-principal investigator from the academic 
institution could receive electronic notifications from the clinical IRB.
The negotiation of authority and control between the academic and 
the clinical IRB respectively, played an important role in our project. 
Initially, the academic staff took the lead in applying for IRB approval 
and submitting amendments when required. Once academic IRB 
approval was received, the clinic staff would submit their requests for 
approval of identical items. We soon discovered that the clinical IRB 
more strict required recognition as the lead IRB – in any study where 
their patients were involved. 
Using the clinical IRB as the “lead” IRB reduced the amount of 
time spent on resubmissions. However, the clinical IRB/compliance 
staff appeared less aware of the project timeline - even halting subject 
recruitment twice at critical times in the recruitment process, while 
compliance staff decided how best to access data from the EHR when 
an academic institution was involved. Three different record-keeping 
systems were identified by the clinical compliance staff – each one used 
then eliminated after a few months – before finally deciding on a workable 
system. Both institutions accepted CITI training [27] for research on 
human subjects, with additional HIPAA modules to be completed.
Conclusions
Qualities characterizing success of multi-site, multi-institutional 
clinical trials include effective communication between the onsite 
coordinators, between the clinic and university-based research teams, 
and between the coordinators and investigators. Of importance also is 
the commitment by all institutions for advance determination of IRB 
processes, joint access to records and data management systems, and 
standardized online training and reporting to eliminate the impact of 
staff transition and attrition. 
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